Risk factors for carcinoma in situ of the breast

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 7, 2000, Pages 697-703

  Trentham Dietz, Amy ^a,c   Newcomb, Polly A ^a,b   Storer, Barry E ^b   Remington, Patrick L ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CARCINOMA IN SITU; CASE CONTROL STUDY; DATA ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; RISK FACTORS;

EID: 0033927857     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Miller, B. A., Feuer, E. J., and Hankey, B. F. The increasing incidence of breast cancer since 1982: relevance of early defection. Cancer Causes Control, 2: 67-74, 1991.
2. White, E., Lee, C. Y., and Kristal, A. R. Evaluation of the increase in breast cancer incidence in relation to mammography use. J. Natl. Cancer Inst., 82: 1546-1552, 1990.
3. Feuer, E. J., and Wun, L. M. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am. J. Epidemiol., 136: 1423-1436, 1992.
4. Lantz, P. M., Remington, P. L., and Newcomb, P. A. Mammography screening and increased incidence of breast cancer in Wisconsin. J. Natl. Cancer Inst., 83: 1540-1546, 1991.
5. Newcomb, P. A., and Lantz, P. M. Recent trends in breast cancer: incidence, mortality, and mammography. Breast Cancer Res. Treat., 28: 97-106, 1993.
6. Simon, M. S., Lemanne, D., Schwartz, A. G., Martino, S., and Swanson, G. M. Recent trends in the incidence of in situ and invasive breast cancer in the Detroit metropolitan area (1975-1988). Cancer (Phila.), 71: 769-764, 1993.
7. Choi, W. S., Parker, B. A., Pierce, J. P., and Greenberg, E. R. Regional differences in the incidence and treatment of carcinoma in situ of the breast. Cancer Epidemiol. Biomark. Prev., 5: 317-320, 1996.
8. Ernster, V. L., Barclay, J., Kerlikowske, K., Grady, D., and Henderson, I. H. Incidence of and treatment for ductal carcinoma in situ of the breast. J. Am. Med. Assoc., 275: 913-918, 1996.
9. Miller, F. R., Soule, H. D., Tait, L., Pauley, R. J., Wolman, S. R., Dawson, P. J., and Heppner, G. H. Xenograft model of progressive human proliferative breast disease. J. Natl. Cancer. Inst., 85: 1725-1732, 1993.
10. Strah, K. M., and Love, S. M. The in situ carcinomas of the breast. J. Am. Med. Womens Assoc., 47: 165-168, 1992.
11. Percy, C., Van Holten, V., and Muir, C. International Classification of Diseases for Oncology, Ed. 2. Geneva, Switzerland: The World Health Organization, 1990.
12. Egan, K. M. Stampfer, M. J., Rosner, B. A., Trichopoulos, D., Newcomb, P. A., Trentham-Dietz, A., Longnecker, M. P., Mittendorf, R., Greenberg, E. R., and Willett, W. C. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol. Biomark. Prev., 7: 359-364, 1998.
13. Longnecker, M. P., Newcomb, P. A., Mittendorf, R., Greenberg, E. R., Clapp, R. W., Bogdan, G., Willett, W. C., and MacMahon, B. The reliability of self-reported alcohol consumption in the remote past. Epidemiology, 3: 535-539, 1992.
14. Trentham-Dietz, A., Newcomb, P. A., Storer, B. E., Longnecker, M. P., Baron, J., Greenberg, E. R., and Willett, W. C. Body size and risk of breast cancer. Am. J. Epidemiol., 145: 1011-1019, 1997.
15. Longnecker, M. P., Newcomb, P. A, Mittendorf, R., Greenberg, E. R., and Willett, W. C. Intake of carrots, spinach, and supplements containing Vitamin A in relation to risk of breast cancer. Cancer Epidemiol. Biomark. Prev., 6: 887-892, 1997.
16. Hosmer, D. W., and Lemeshow, S. Applied Logistic Regression, pp. 216-232, New York: Wiley, 1989.
17. Weiss, H. A., Brinton, L. A., Brogan, D., Coates, R. J., Gammon, M. D., Malone, K. E., Schoenberg, J. B., and Swanson, C. A. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br. J. Cancer, 73: 1298-1305, 1996.
18. Brinton, L. A., Hoover, R., and Fraumeni, J. F., Jr. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br. J. Cancer, 54: 825-832, 1986.
19. Longnecker, M. P., Bernstein, L., Paganini-Hill, A., Enger, S. M., and Ross, R. K. Risk factors for in situ breast cancer. Cancer Epidemiol. Biomark. Prev., 5: 961-965, 1996.
20. Kerlikowske, K., Barclay, J., Grady, D., Sickles, E. A., and Emster, V. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J. Natl. Cancer. Inst., 89: 77-82, 1997.
21. Brinton, L. A., Hoover, R., and Fraumeni, J. F., Jr. Epidemiology of minimal breast cancer. J. Am. Med. Assoc., 249: 483-487, 1983.
22. Dubin, N., Hutter, R. V. P., Strax, P., Fazzini, E. P., Schinella, R. A., Batang, E. S., and Pasternack, B. S. Epidemiology of minimal breast cancer among women screened in New York City. J. Natl. Cancer Inst., 73: 1273-1279, 1984.
23. Schairer, C., Byrne, C., Keyl, P. M., Brinton, L. A., Sturgeon, S. R., and Hoover, R. N. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control, 5: 491-500, 1994.
24. Lambe, M., Hsieh, C-C., Tsaih, S-W., Ekbom, A., Trichopoulos, D., and Adami, H-O. Parity, age at first birth and the risk of carcinoma in situ of the breast. Int. J. Cancer, 77: 330-332, 1998.
25. Henrich, J. B., Kornguth, P. J., Viscoli, C. M., and Horwitz, R. I. Post-menopausal estrogen use and invasive versus in situ breast cancer risk. J. Clin. Epidemiol., 51: 1277-1283, 1998.
26. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Starnpfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E. Use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med., 332: 1589-1593, 1995.
27. Stanford, J. L., Weiss, N. S., Voigt, L. F., Daling, J. R., Habel, L. A., and Rossing, M. A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J. Am. Med. Assoc., 274: 137-142, 1995.
28. Gapstur, S. M., Morrow, M., and Sellers, T. A. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. J. Am. Med. Assoc., 281: 2091-2097, 1999.
29. Wysowski, D. K., Golden, L., and Burke, L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet. Gynecol., 85: 6-10, 1995.
30. Breen, N., and Kessler, L. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. Am. J. Public Health, 84: 62-67, 1994.
31. Seeley, T. Do women taking hormone replacement therapy have a higher uptake of screening mammograms? Maturitas, 19: 93-96, 1994.
32. Greendale, G. A., Reboussin, B. A., Sie, A., Singh, H. R., Olson, L. K., Gatewood, O., Bassett, L. W., Wasilauskas, C., Bush, T., and Barren-Connor, E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann. Intern. Med., 130: 262-269, 1999.
33. Persson, I., Thurfjell, E., and Holmberg, L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J. Clin. Oncol., 15: 3201-3207, 1997.
34. Laya, M. B., Larson, E. B., Taplin, S. H., and White, E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J. Natl. Cancer Inst., 88: 643-649, 1996.
35. Newcomer, L. M., Newcomb, P. A., Daling, J. R., Yasui, Y., and Potter, J. D. Postmenopausal hormone use and risk of cancer by histologic type. Am. J. Epidemiol., 149: S79, 1999.
36. Millikan, R., Dressier, L., Geradts, J., and Graham, M. The need for epidemiologic studies of in situ carcinoma of the breast. Breast Cancer Res. Treat., 35: 65-77, 1995.